TargetLeucine-rich repeat serine/threonine-protein kinase 2(Homo sapiens (Human))
Medical Research Council Technology
US Patent
Medical Research Council Technology
US Patent
Affinity DataKi: 26nMAssay Description:This assay was used to determine a compound's potency in inhibiting activity of LRRK2 by determining Kiapp, IC50 or percent inhibition values.More data for this Ligand-Target Pair